Deficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesis

Carcinogenesis

Volumn 33, Issue 6, 2012, Pages 1239-1246

  Li, Juan ^a,b   Zheng, Hai ^b   Yu, Fang ^a   Yu, Tianxin ^c   Liu, Chunming ^c   Huang, Shiang ^b   Wang, Timothy C ^d   Ai, Walden ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF KENTUCKY   (United States)

^d Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL CARCINOMA; CANCER CELL; CANCER TISSUE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; COHORT ANALYSIS; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; GENE INACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINOCYTES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, TRANSGENIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; SKIN NEOPLASMS; TAMOXIFEN; TETRADECANOYLPHORBOL ACETATE;

EID: 84862657001     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs143     Document Type: Article

References (53)

1. Shields, J.M. et al. (1996) Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J. Biol. Chem., 271, 20009-20017.
2. Yet, S.F. et al. (1998) Human EZF, a Kruppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J. Biol. Chem., 273, 1026-1031.
3. Garrett-Sinha, L.A. et al. (1996) A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J. Biol. Chem., 271, 31384-31390.
4. Ghaleb, A.M. et al. (2005) Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res., 15, 92-96.
5. Evans, P.M. et al. (2008) Roles of Krupel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim. Biophys. Sin. (Shanghai), 40, 554-564.
6. Mahatan, C.S. et al. (1999) Characterization of the structure and regulation of the murine gene encoding gut-enriched Kruppel-like factor (Kruppellike factor 4). Nucleic Acids Res., 27, 4562-4569.
7. Nickenig, G. et al. (2002) Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo. FASEB J., 16, 1077-1086.
8. Chen, X. et al. (2003) Transcriptional profiling of Kruppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. J. Mol. Biol., 326, 665-677.
9. Shie, J.L. et al. (2000) Gut-enriched Kruppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res., 28, 2969-2976.
10. Yoon, H.S. et al. (2004) Requirement of Kruppel-like factor 4 in preventing entry into mitosis following DNA damage. J. Biol. Chem., 279, 5035-5041.
11. Li, Y. et al. (2005) Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood, 105, 635-637.
12. Bruce, S.J. et al. (2007) Dynamic transcription programs during ES cell differentiation towards mesoderm in serum versus serum-freeBMP4 culture. BMC Genomics, 8, 365.
13. Okita, K. et al. (2010) Induction of pluripotency by defined factors. Exp. Cell Res., 316, 2565-2570.
14. Yu, F. et al. (2011) Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene, 30, 2161-2172.
15. Segre, J.A. et al. (1999) Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet., 22, 356-360.
16. Katz, J.P. et al. (2005) Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology, 128, 935-945.
17. Rowland, B.D. et al. (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nat. Rev. Cancer, 6, 11-23.
18. Gebhardt, C. et al. (2008) RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med., 205, 275-285.
19. Dominguez, M. et al. (1996) Sending and receiving the hedgehog signal: control by the Drosophila Gli protein Cubitus interruptus. Science, 272, 1621-1625.
20. Johnson, R.L. et al. (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science, 272, 1668-1671.
21. Kinzler, K.W. et al. (1997) Cancer-susceptibility genes. Gatekeepers and caretakers. Nature, 386, 761, 763.
22. Taipale, J. et al. (2001) The Hedgehog and Wnt signalling pathways in cancer. Nature, 411, 349-354.
23. Sancho, E. et al. (2003) Live and let die in the intestinal epithelium. Curr. Opin. Cell Biol., 15, 763-770.
24. Foster, K.W. et al. (2005) Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene, 24, 1491-1500.
25. Wei, D. et al. (2006) Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis, 27, 23-31.
26. Ohnishi, S. et al. (2003) Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem. Biophys. Res. Commun., 308, 251-256.
27. Choi, B.J. et al. (2006) Altered expression of the KLF4 in colorectal cancers. Pathol. Res. Pract., 202, 585-589
28. Pandya, A.Y. et al. (2004) Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin. Cancer Res., 10, 2709-2719.
29. Choi, W.J. et al. (2011) The role of KLF4 in UVB-induced murine skin tumor development and its correlation with cyclin D1, p53, and p21(Waf1/ Cip1) in epithelial tumors of the human skin. Arch. Dermatol. Res., 303, 191-200.
30. Zhang, W. et al. (2006) Novel cross talk of Kruppel-like factor 4 and betacatenin regulates normal intestinal homeostasis and tumor repression. Mol. Cell. Biol., 26, 2055-2064.
31. Rowland, B.D. et al. (2005) The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol., 7, 1074-1082.
32. Ai, W. et al. (2004) Kruppel-like factor 4 (KLF4) represses histidine decarboxylase gene expression through an upstream Sp1 site and downstream gastrin responsive elements. J. Biol. Chem., 279, 8684-8693.
33. Hara-Chikuma, M. et al. (2008) Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing. J. Mol. Med., 86, 221-231.
34. Wu, W.Y. et al. (2005) Method for the harvest and assay of in vitro clonogenic keratinocytes stem cells from mice. Methods Mol. Biol., 289, 79-86.
35. Jensen, K.B. et al. (2010) Assaying proliferation and differentiation capacity of stem cells using disaggregated adult mouse epidermis. Nat. Protoc., 5, 898-911.
36. Lee, E.C. et al. (2001) A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics, 73, 56-65.
37. Katz, J.P. et al. (2002) The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development, 129, 2619-2628.
38. Chen, X. et al. (2001) Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem., 276, 30423-30428.
39. Yang, J. et al. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell, 14, 818-829.
40. Wei, D. et al. (2008) Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res., 68, 4631-4639.
41. Wei, D. et al. (2010) KLF4alpha up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology, 139, 2135-2145.
42. Tetreault, M.P. et al. (2010) Esophageal squamous cell dysplasia and delayed differentiation with deletion of kruppel-like factor 4 in murine esophagus. Gastroenterology, 139, 171-181 e9.
43. Tetreault, M.P. et al. (2010) Klf4 overexpression activates epithelial cytokines and inflammation-mediated esophageal squamous cell cancer in mice. Gastroenterology, 139, 2124-2134 e9.
44. Feinberg, M.W. et al. (2005) Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J. Biol. Chem., 280, 38247- 38258.
45. Alder, J.K. et al. (2008) Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo. J. Immunol., 180, 5645-5652.
46. Gonda, T.A. et al. (2009) Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle, 8, 2005-2013.
47. Watson, M.A. et al. (1995) H-ras oncogene mutation spectra in B6C3F1 and C57BL/6 mouse liver tumors provide evidence for TCDD promotion of spontaneous and vinyl carbamate-initiated liver cells. Carcinogenesis, 16, 1705-1710.
48. Binder, R.L. et al. (1998) Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen. Cancer Res., 58, 4314-4323.
49. Laiho, M. et al. (2003) Cell cycle control, DNA damage checkpoints and cancer. Ann. Med., 35, 391-397.
50. Miller, K.A. et al. (2001) Kruppel-like factor 4 regulates laminin alpha 3A expression in mammary epithelial cells. J. Biol. Chem., 276, 42863- 42868.
51. Wang, H. et al. (2004) The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells. J. Biol. Chem., 279, 22674-22683.
52. Dang, D.T. et al. (2003) Overexpression of Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene, 22, 3424-3430.
53. Gomes, L.R. et al. (2011) Epithelial-mesenchymal transition: implications in cancer progression and metastasis. Curr. Pharm. Biotechnol., 12, 1881- 1890.